• Tacrine Hydrochloride Hydrate: Benchmark Acetylcholineste...

  2026-01-21

  Tacrine hydrochloride hydrate is a high-purity, highly soluble acetylcholinesterase inhibitor widely used in neurodegenerative disease research. Its molecular specificity and robust assay performance make it a gold standard compound for modeling cholinergic signaling and enzyme inhibition in Alzheimer's disease workflows.

• Strategic Horizons in Translational Research: Advancing D...

  2026-01-21

  This thought-leadership article explores the mechanistic and translational promise of Fasudil (HA-1077) HCl as a selective Rho-associated protein kinase (ROCK) inhibitor. We delve into the biological rationale underpinning Rho/ROCK pathway targeting, integrate recent evidence—including Hippo pathway crosstalk and new cancer models—and offer strategic guidance for translational researchers. By contextualizing APExBIO’s Fasudil within the emerging competitive and experimental landscape, we provide a visionary outlook on leveraging this compound for next-generation disease models and therapeutic innovation, far exceeding the scope of standard product pages.

• DiscoveryProbe™ Bioactive Compound Library Plus: Redefini...

  2026-01-20

  Explore how the DiscoveryProbe Bioactive Compound Library Plus empowers high-throughput ligand identification and pathway deconvolution beyond conventional screening. This in-depth review highlights unique applications for apoptosis, cancer, immunology, and neurodegenerative disease research, setting it apart from standard compound libraries.

• Metronidazole as an OAT3 Inhibitor: New Frontiers in Immu...

  2026-01-20

  Explore the advanced scientific roles of Metronidazole as a nitroimidazole antibiotic and OAT3 inhibitor in immune-microbiome research. This article unveils novel applications and mechanistic insights distinct from existing guides, with actionable directions for antibiotic research and drug-drug interaction studies.

454 records 31/31 page Previous First page 上5页 31